Embolization Coil Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Denmark, China, Canada, India - Size and Forecast 2024-2028

Embolization Coil Market Size 2024-2028

The embolization coil market size is forecast to increase by USD 538.3 million at a CAGR of 6% between 2023 and 2028.

• The market is witnessing significant growth due to the increasing incidence of aneurysms, a condition that requires intervention with embolization coils and aneurysm coiling and embolization devices. This trend is further fueled by technological advances in embolization coils, which offer improved efficacy and safety.
• However, the market also faces challenges from the complications associated with the use of embolization coils, such as coil migration and thromboembolism. These factors are driving the market's dynamics and shaping its future growth trajectory. The market's growth is underpinned by the rising prevalence of aneurysms and the ongoing technological innovations in medical devices.
• Despite the challenges, the market's future looks promising, with opportunities for growth in emerging markets and the development of advanced coil designs.

What will be the Size of the Embolization Coil Market During the Forecast Period?

Request Free Sample

• The market caters to the growing demand for minimally invasive treatments and angiography devices for various blood-related conditions, including brain aneurysms, cardiac aneurysms, ischemic heart disease, and peripheral vascular diseases. Embolization coils are used in surgical procedures to block the flow of oxygenated blood in arteries and veins, thereby treating conditions such as arteriovenous malformations, tumors in the liver, kidney, and neuroendocrine system, and aortic artery disorders.
• These procedures offer several advantages over traditional open surgeries, including reduced recovery time, minimal scarring, and lower risk of complications. The World Health Organization estimates that cardiovascular diseases, including brain aneurysms and ischemic heart disease, account for over 17 million deaths annually, which will drive the need for cardiovascular medical devices.
• Symptoms of these conditions may include headaches, neck pain, upper back pain, nausea, and vomiting. The market is expected to grow significantly due to the increasing prevalence of these conditions and the rising demand for minimally invasive procedures.

How is this Embolization Coil Industry segmented and which is the largest segment?

The embolization coil industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Application
  • Neurology
  • Oncology
  • Peripheral vascular disease
  • Cardiology
  • Others
• Type
  • Detachable coil
  • Pushable coil
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Denmark
  • Asia
    • China
    • India
  • Rest of World (ROW)

By Application Insights

• The neurology segment is estimated to witness significant growth during the forecast period.

Neurological disorders, encompassing conditions such as brain tumors, stroke, and aneurysms, pose significant health challenges due to their impact on the nervous system. These disorders result from structural, biochemical, and electrical abnormalities in the brain, nerves, and spinal cord. Symptoms vary widely, ranging from pain and muscle weakness to seizures and loss of sensation. Treatment approaches include medication and interventional procedures, with embolization coils utilized for managing brain aneurysms and arteriovenous malformations (AVM)/fistulas. Embolization coils are essential tools in neurointerventional radiology, used to occlude blood vessels supplying the aneurysm or AVM sac. These coils, available in detachable and pushable forms, are made of materials like platinum, hydrogel, and platinum tungsten alloy.

Neurological conditions, including brain aneurysms, cardiac aneurysms, and neuroendocrine tumors, can be caused by factors such as family history, inheritance, tobacco use, unhealthy diet, physical inactivity, and various blood-related conditions like high blood pressure, high cholesterol, and arterial defects. Embolization procedures involve the use of a steerable catheter to navigate the arterial system, followed by coil embolization to occlude the target vessel. Potential complications include bleeding, coil migration, coil misplacement, coil retrieval issues, coil stretching, non-target embolization, aneurysmal perforation, rupture, parent artery occlusion, cerebral embolism, neurological impairments, stroke, and death. Hospitals, cardiac centers, ambulatory centers, and diagnostic centers employ interventional radiologists to perform these procedures, using peripheral embolization devices like microcatheters from manufacturers like Terumo.

The embolization market caters to various therapeutic areas, including neurology, cardiology, urology, oncology, and peripheral vascular disease. The World Health Organization and government programs play a crucial role in shaping healthcare systems and increasing access to these advanced interventions. Minimally invasive procedures, such as embolization, have gained popularity due to their reduced risk profile compared to traditional open surgeries. However, they require skilled professionals and advanced equipment, necessitating ongoing investment in training and technology.

Get a glance at the Embolization Coil Industry report of share of various segments Request Free Sample

The Neurology segment was valued at USD 580.10 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

• North America is estimated to contribute 41% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The market in North America is driven by the advanced healthcare infrastructure, highly skilled professionals, and extensive healthcare insurance coverage. The US dominates the market due to the high adoption of technologically advanced products and CMS's extensive insurance coverage. Increasing research and development expenditure and the availability of minimally invasive treatments are also significant growth factors. Embolization coils are used to treat various conditions, including brain aneurysms, cardiac aneurysms, blood related conditions, and tumors. These coils are made of materials such as platinum, hydrogel, and Platinum tungsten alloy. Neurology, cardiology, urology, oncology, and peripheral vascular disease are the major application areas.

Coil embolization is a minimally invasive procedure that involves the use of a steerable catheter to deliver the coil to the target site, where it is released to block blood flow to the affected area. Complications include coil migration, misplacement, and retrieval issues. Conditions such as ischemic heart disease, cardiovascular diseases, rheumatic heart disease, tobacco use, unhealthy diet, physical inactivity, and family history increase the risk of aneurysms and cancer cases. Diabetes and hypervascular tumors are also common indications for embolization coil therapy. The World Health Organization and various government programs and healthcare systems support the use of therapeutic devices to prevent rupturing and improve patient monitoring. Peripheral embolization devices, such as electrophysiology catheters, are also used to treat peripheral vascular arteries and aortic aneurysms.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise In the adoption of Embolization Coil Industry?

Increasing incidence of aneurysms is the key driver of the market.

• Aneurysms are medical conditions characterized by the weakening of an artery's wall, leading to the formation of a bulge or sac In the artery. Aneurysms can affect various parts of the body, including the heart, brain, kidney, liver, and aorta. Among the different types, aortic aneurysms and cerebral aneurysms are the most common, affecting a significant global population. Brain aneurysms, which occur when blood vessels In the brain bulge or balloon, are particularly prevalent among individuals aged 35-40 years. In the US, the annual brain aneurysm rupture rate is approximately 9 cases per 100,000 population, with women being more susceptible than men (3:2 ratio).
• Cardiac aneurysms, caused by weakness In the heart's arterial walls, can lead to life-threatening complications such as heart attacks and strokes. Other conditions, including tobacco use, unhealthy diet, physical inactivity, high blood pressure, high cholesterol, arterial defects, and a family history of aneurysms, can increase the risk of developing these conditions. Surgical embolization, a minimally invasive procedure, is a common treatment for various aneurysms, including brain, cardiac, and peripheral vascular diseases. This procedure involves the use of embolization coils, which can be detachable or pushable, made of platinum, hydrogel, or platinum tungsten alloy. Coil embolization aims to block the blood flow to the aneurysm sac, preventing further expansion and rupture.
• Conditions such as ischemic heart disease, cardiovascular diseases, rheumatic heart disease, bronchial artery embolization, cerebrovascular disease, coronary heart disease, and rheumatic heart disease can also benefit from embolization coil technology. Interventional radiology plays a crucial role in the diagnosis and treatment of these conditions, using steerable catheters and endovascular surgery to deliver the coils to the target site. Despite the benefits, embolization coil procedures come with risks such as bleeding, coil migration, coil misplacement, coil retrieval issues, coil stretching, non-target embolization, aneurysmal perforation, rupture, parent artery occlusion, cerebral embolism, neurological impairments, stroke, and death. Puncture site hematoma, thromboembolic events, discomfort, vasospasm, infection, vascular thrombosis, clot formation, ischemia, reprocessing, sterilization, mechanical issues, console flaws, cross contamination, and hospital-acquired infections are some of the complications associated with the use of embolization coils.
• The market caters to various medical segments, including neurology, cardiology, urology, oncology, and peripheral vascular disease. Companies such as Terumo, with a broad embolization range, play a significant role in the development and production of these devices. Blood flow in peripheral vascular arteries and aortic aneurysms can be affected by these conditions, leading to a need for embolization coils to maintain proper blood flow and prevent complications. Government programs and the healthcare system play a crucial role In the adoption and accessibility of embolization coil technology. The increasing prevalence of conditions such as diabetes, liver cancer, kidney cancer, and hypervascular tumors further drives the demand for these devices.
• The use of 3D embolization coils, miniaturized coils, and hydrocoils with a conformable 3D shape and tiny coils enables better coiling and clipping, improving patient outcomes and reducing complications. Embolization coils are essential therapeutic devices used to treat various blood-related conditions, including aneurysms, tumors, and vascular diseases. The growing prevalence of these conditions, coupled with advancements in technology and the increasing adoption of minimally invasive procedures, is driving the growth of the market. However, the risks associated with these procedures necessitate proper patient monitoring, disease identification, and the development of reliable and effective therapeutic devices to ensure optimal patient outcomes.

What are the market trends shaping the Embolization Coil Industry?

Technological advances in embolization coil is the upcoming market trend.

• The market is witnessing significant growth due to the increasing prevalence of various blood-related conditions such as brain aneurysms, cardiac aneurysms, and peripheral vascular diseases. These conditions require minimally invasive procedures like surgical embolization using embolization coils for effective treatment. The market is driven by technological advances and innovations, including the development of 3D embolization coils, miniaturized coils, hydrocoils, and coils with integrated deployment mechanisms. For instance, 3D embolization coils, which have a conformable 3D shape, offer improved precise multi-planar deployment and accelerate thrombus formation. They also provide flexible access to both smaller and larger blood vessels, making them suitable for the treatment of difficult wide-necked aneurysms or high-flow territories.
• Other conditions treated with embolization coils include liver and kidney cancer, neuroendocrine tumors, aortic artery disorders, and arteriovenous malformations. Factors contributing to the market growth include the rising incidence of ischemic heart disease, cardiovascular diseases, rheumatic heart disease, and tobacco use, as well as unhealthy diets and physical inactivity. Additionally, government programs and improvements In the healthcare system have increased access to diagnostic and therapeutic devices, leading to a higher demand for embolization coils. Despite the benefits, challenges such as coil embolization bleeding, sac rupturing, coil migration, misplacement, and retrieval issues persist. These complications can result in coil stretching, non-target embolization, aneurysmal perforation, and rupture, leading to neurological impairments, strokes, and even death.
• Other complications include puncture site hematoma, thromboembolic events, discomfort, vasospasm, infection, vascular thrombosis, clot formation, ischemia, reprocessing, sterilization, mechanical issues, console flaws, and cross contamination. The market is segmented by application into neurology, cardiology, urology, oncology, and peripheral vascular disease. The neurology segment dominates the market due to the high prevalence of cerebrovascular diseases, including brain aneurysms and cerebral embolism. The market is also driven by the development of new materials such as platinum, hydrogel, and platinum tungsten alloy, which offer improved performance and safety. The market is expected to grow significantly due to the increasing prevalence of various blood-related conditions and the development of advanced embolization coils.
• However, challenges such as complications and regulatory requirements must be addressed to ensure patient safety and market growth.

What challenges does the Embolization Coil Industry face during its growth?

Complications associated with use of embolization coils is a key challenge affecting the industry growth.

• Embolization coils are used in minimally invasive procedures to treat various blood-related conditions, including brain aneurysms, cardiac aneurysms, and tumors such as liver cancer, kidney cancer, neuroendocrine tumors, and peripheral vascular diseases. Surgical embolization using embolization coils is a common treatment for aortic artery disorders, arteriovenous malformations, and bronchial artery embolization. The Neurology, Cardiology, Urology, and Oncology segments are significant markets for embolization coils. Complications from embolization coil procedures include aneurysmal perforation and rupture, parent artery occlusion, cerebral embolism, neurological impairments such as stroke and death, and puncture site hematoma. Thromboembolic events, pain, vasospasm, infection, vascular thrombosis, clot formation, hemorrhage, and ischemia are other risks associated with embolization coils.
• The use of embolization coils requires careful patient monitoring for coil migration, misplacement, coil retrieval issues, coil stretching, and non-target embolization. The market includes various types of coils, such as detachable and pushable ones, made of materials like platinum, hydrogel, and platinum tungsten alloy. The coils come in different shapes and sizes to fit various arteries and arterial walls. Common complications include bleeding from the sac, steerable catheter issues, and endovascular surgery-related complications. Government programs and the healthcare system play a significant role In the market, with hospitals, cardiac centers, ambulatory centers, and diagnostic centers being major consumers. Peripheral embolization devices, such as microcatheters, are also essential components of the market.
• Embolization coils are used to treat various conditions, including ischemic heart disease, cardiovascular diseases, rheumatic heart disease, tobacco use, unhealthy diet, physical inactivity, abdominal aortic aneurysm, thoracic aortic aneurysm, and family history or inheritance of aneurysms. Symptoms such as headaches, neck pain, upper back pain, nausea, and vomiting may indicate the need for embolization coil treatment. Complications from embolization coil procedures can lead to discomfort, vasospasm, infection, and mechanical issues, including console flaws and cross contamination. Proper sterilization and reprocessing of embolization coils are crucial to prevent complications and ensure patient safety.

Exclusive Customer Landscape

The embolization coil market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the embolization coil market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, embolization coil market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

Abbott Laboratories - The company specializes in providing embolization coils and associated offerings, including the Amplatzer Vascular Plug II, to cater to the medical industry's needs for minimally invasive treatments.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• Achieva Medical
• BALT Group
• Boston Scientific Corp.
• Braile Biomedica
• Cordis Corp.
• Cook Group Inc.
• Grand Pharmaceutical Group Ltd
• Johnson and Johnson Services Inc.
• Kaneka Corp.
• Lepu Medical Technology Beijing Co. Ltd.
• Medtronic PLC
• Merit Medical Systems Inc.
• MicroPort Scientific Corp.
• Penumbra Inc.
• phenox GmbH
• Shape Memory Medical Inc.
• Sirtex Medical Pty Ltd.
• Stryker Corp.
• Terumo Medical Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Embolization coils have emerged as a prominent solution In the medical field for the treatment of various vascular and neurological conditions. These devices, used in minimally invasive procedures, play a crucial role in obstructing the flow of blood in targeted areas, thereby facilitating the healing process. The market encompasses a wide range of applications, including the neurology, cardiology, urology, oncology, and peripheral vascular disease segments. Neurological conditions such as aneurysms, arteriovenous malformations, and cerebrovascular diseases are among the primary indications for embolization coil use. Embolization coils are available in various forms, including detachable and pushable ones. Detachable coils, which can be released at the desired location, offer greater precision and control during the procedure.

Pushable coils, on the other hand, are advanced through the catheter until they reach the target site and expand upon deployment. The arterial system, including the aortic artery and its branches, is a common application area for embolization coils. Aortic aneurysms, both abdominal and thoracic, pose a significant risk to patients due to their potential for rupture. Embolization coils can help prevent this risk by occluding the aneurysm sac. Cardiovascular diseases, such as ischemic heart disease, coronary heart disease, rheumatic heart disease, and tobacco use-related conditions, can also benefit from embolization coil therapy. These conditions can lead to blockages in the arteries and veins, which can be treated by embolizing the affected area.

The liver, kidneys, and other organs can also be targeted for embolization coil therapy In the treatment of tumors and cancer cases. Hypervascular tumors, in particular, can be effectively treated by occluding the blood supply to the tumor using embolization coils. Peripheral vascular diseases, such as those affecting the legs and arms, can also be treated using embolization coils. These conditions can lead to discomfort, pain, and even life-threatening complications if left untreated. The use of embolization coils carries certain risks, including bleeding, coil migration, coil misplacement, coil retrieval issues, coil stretching, non-target embolization, aneurysmal perforation, rupture, parent artery occlusion, cerebral embolism, neurological impairments, stroke, death, puncture site hematoma, thromboembolic events, discomfort, vasospasm, infection, vascular thrombosis, clot formation, ischemia, reprocessing, sterilization, mechanical issues, console flaws, and cross contamination.

Despite these risks, embolization coils remain a valuable tool in the medical arsenal for the treatment of various conditions. The healthcare system and government programs play a crucial role in ensuring the availability and accessibility of these therapeutic devices to patients in need. The market continues to evolve, with advancements in materials, such as platinum, hydrogel, and platinum tungsten alloy, and technologies, such as 3D embolization coils and miniaturized coils, driving innovation and improving patient outcomes. The future of embolization coil therapy holds great promise In the treatment of an increasingly diverse range of conditions.

Request Free Sample

What are the Key Data Covered in this Embolization Coil Market Research and Growth Report?

• CAGR of the Embolization Coil industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the embolization coil market growth of industry companies

We can help! Our analysts can customize this embolization coil market research report to meet your requirements.

Get in touch